BeStock  
Stocks › EWTX

Edgewise Therapeutics EWTX

US equityMarket cap rank #2209Biotechnology
$40.30 −$1.10 (-2.66%)
Market closed · Oct 5, 10:20 pm ET · Last extended-hours $40.30 0.00%
Open$41.55
Prev close$41.40
Day range$39.98 – $41.79
Volume1.63M
Market cap$4.38B
P/E (TTM)–
Dividend yield–

EWTX Stock News

Headlines matching Edgewise Therapeutics or the EWTX ticker, most recent first.

  • Analysts Are Bullish on These Healthcare Stocks: Prime Medicine, Inc. (PRME), Edgewise Therapeutics (EWTX)TipRanks · 25 Sep 2026
  • RBC Capital Maintains Edgewise Therapeutics(EWTX.US) With Buy Rating, Maintains Target Price $59Market news · 23 Sep 2026
  • Truist Financial Maintains Edgewise Therapeutics(EWTX.US) With Buy RatingMarket news · 23 Sep 2026
  • H.C. Wainwright Maintains Edgewise Therapeutics(EWTX.US) With Buy Rating, Maintains Target Price $57Market news · 23 Sep 2026
  • Wedbush Maintains Edgewise Therapeutics(EWTX.US) With Buy Rating, Raises Target Price to $53Market news · 23 Sep 2026
  • Analysts Offer Insights on Healthcare Companies: Eledon Pharmaceuticals (ELDN), Lexeo Therapeutics, Inc. (LXEO) and Edgewise Therapeutics (EWTX)TipRanks · 23 Sep 2026
  • H.C. Wainwright Initiates Edgewise Therapeutics(EWTX.US) With Buy Rating, Announces Target Price $57Market news · 21 Sep 2026
  • H.C. Wainwright Maintains Edgewise Therapeutics(EWTX.US) With Buy Rating, Maintains Target Price $45Market news · 7 Aug 2026
  • Evercore Maintains Edgewise Therapeutics(EWTX.US) With Buy Rating, Maintains Target Price $55Market news · 7 Aug 2026
  • J.P. Morgan Maintains Edgewise Therapeutics(EWTX.US) With Buy Rating, Raises Target Price to $60Market news · 20 Aug 2026
  • J.P. Morgan Maintains Edgewise Therapeutics(EWTX.US) With Buy Rating, Maintains Target Price $60Market news · 20 Aug 2026
  • Guggenheim Maintains Edgewise Therapeutics(EWTX.US) With Buy Rating, Raises Target Price to $51Market news · 6 Jul 2026
  • Evercore Maintains Edgewise Therapeutics(EWTX.US) With Buy Rating, Raises Target Price to $55Market news · 20 Jul 2026
  • Oppenheimer Initiates Edgewise Therapeutics(EWTX.US) With Buy Rating, Announces Target Price $51Market news · 10 Jul 2026
  • J.P. Morgan Maintains Edgewise Therapeutics(EWTX.US) With Buy Rating, Raises Target Price to $53Market news · 6 Jun 2026

Discussion

No comments yet — be the first to weigh in on EWTX.

Leave a comment

Scroll to Top